We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-19.29%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
AUM
$2.05B
AUM Growth
+$535M
Cap. Flow
+$966M
Cap. Flow %
47.2%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$966M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$898M 43.86%
+58,807,379
New +$966M
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
$616M 30.07%
38,296,526
EVLO
3
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$237M 11.58%
911,670
DNLI icon
4
Denali Therapeutics
DNLI
$3.67B
$184M 9%
8,918,749
MCRB icon
5
Seres Therapeutics
MCRB
$48.1M
$57.3M 2.8%
634,144
QTRX icon
6
Quanterix
QTRX
$173M
$37.2M 1.82%
2,030,495
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$17.8M 0.87%
320,444

Similar funds

Flagship Pioneering's Q4 2018 Portfolio in Review

As of Q4 2018, Flagship Pioneering held 7 positions worth $2.05B, up 35% from $1.51B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering deployed $966M of net new capital in Q4 2018, opening 1 new position. Its largest new stake was Moderna: 58,807,379 shares worth $898M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's largest Q4 2018 buy was Moderna: 58,807,379 shares worth $898M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $2.05B portfolio in Q4 2018.
  • Flagship Pioneering opened 1 new position and closed 0 in Q4 2018.
  • Flagship Pioneering's portfolio value rose 35% quarter-over-quarter to $2.05B.

Based on Flagship Pioneering's 13F filing for Q4 2018, filed 13 Feb 2019.